The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multinational, randomized, phase III trial of XELIRI (+bevacizumab) versus FOLFIRI (+bevacizumab) as the second-line chemotherapy for metastatic colorectal cancer: Asian XELIRI project (AXEPT).
 
Kei Muro
Honoraria - Chugai Pharma; Takeda; Yakult Honsha
Consulting or Advisory Role - Takeda
 
Tae Won Kim
Research Funding - Bayer (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
 
Young Suk Park
No Relationships to Disclose
 
Hiroyuki Uetake
No Relationships to Disclose
 
Tomohiro Nishina
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda
 
Hiroaki Nozawa
No Relationships to Disclose
 
Hiroshi Matsumoto
Speakers' Bureau - Chugai Pharma; Taiho Pharmaceutical
 
Kentaro Yamazaki
Speakers' Bureau - Chugai Pharma; Daiichi Sankyo; Yakult Honsha
 
Sae-Won Han
No Relationships to Disclose
 
Keun-Wook Lee
Research Funding - AstraZeneca (Inst); Genentech (Inst); Hanmi (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst)
 
Yanhong Deng
No Relationships to Disclose
 
Marc E. Buyse
Employment - IDDI
Stock and Other Ownership Interests - IDDI
 
Taroh Satoh
Consulting or Advisory Role - Bristol-Myers Squibb Japan; Lilly Japan; Merck Serono
Research Funding - Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Merck Serono (Inst); Yakult Honsha (Inst)
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose
 
Satoru Iwasa
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma (Inst)
 
Satoshi Morita
Honoraria - Chugai Pharma; Daiichi Sankyo
Speakers' Bureau - Chugai Pharma
 
Junichi Sakamoto
No Relationships to Disclose
 
Rui-hua Xu
No Relationships to Disclose